Pharmacotherapy of social anxiety disorder

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 17, 1998, Pages 47-51

  Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BROFAROMINE; CLONAZEPAM; FLUVOXAMINE; MOCLOBEMIDE; PAROXETINE; SERTRALINE;

CONFERENCE PAPER; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SOCIAL PHOBIA; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; BENZODIAZEPINES; CLINICAL TRIALS; HUMANS; MONOAMINE OXIDASE INHIBITORS; MULTICENTER STUDIES; PHOBIC DISORDERS; PROGNOSIS; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0031792868     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Schneier FR, Johnson J, Hornig CD, et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992;49: 282-288
2. Gelernter CS, Uhde TW, Cimbolic P, et al. Cognitive-behavioral and pharmacological treatment of social phobia: a controlled study. Arch Gen Psychiatry 1991;48:938-945
3. Liebowitz MR, Schneier F, Campeas R, et al. Phenelzine vs atenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 1992; 49:290-300
4. Versiani M, Nardi AE, Mundim FD, et al. Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992;161:353-360
5. Noyes R Jr, Moroz G, Davidson JRT, et al. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 1997;17:247-254
6. Schneier FR, Goetz D, Campeas R, et al. Placebo-controlled trial of moclobemide in social phobia. Br J Psychiatry 1998;172:70-77
7. The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia: a double-blind, placebo-controlled clinical study. Eur Arch Psychiatry Clin Neurosci 1997;247:71-80
8. Fahlen T, Nilsson HL, Borg K, et al. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine: a double-blind, placebo-controlled study. Acta Psychiatr Scand 1995;92:351-358
9. Lott M, Greist JH, Jefferson JW, et al. Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study. J Clin Psychopharmacol 1997;17:255-260
10. van Vliet IM, den Boer JA, Westenberg HG. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 1992;2:21-29
11. Mancini C, Van Ameringen M. Paroxetine in social phobia. J Clin Psychiatry 1996;57:519-522
12. Stein MB, Chartier MJ, Hazen AL, et al. Paroxetine in the treatment of generalised social phobia: open-label treatment and double-blind placebo-controlled discontinuation. J Clin Psychopharmacol 1996;16:218-222
13. Stein MB, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA 1998;280:708-713
14. Katzelnick DJ, Kobak KA, Greist JH, et al. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152:1368-1371
15. van Vliet IM, den Boer JA, Westenberg HG. Psychopharmacological treatment of social phobia: a double blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 1994;115:128-134
16. Van Ameringen M, Mancini C, Streiner DL. Fluoxetine efficacy in social-phobia. J Clin Psychiatry 1993;54:27-32
17. Lepola U, Koponen H, Leinonen E. Citalopram in the treatment of social phobia: a report of three cases. Pharmacopsychiatry 1994;27:186-188
18. Davidson JRT, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428
19. James IM, Griffith DN, Pearson RM, et al. Effect of oxprenolol on stage-fright in musicians. Lancet 1977;2:952-954
20. Turner SM, Beidel DC, Jacob RG. Social phobia: a comparison of behavior therapy and atenolol. J Consult Clin Psychol 1994;62:350-358
21. Connor KM, Davidson JRT, Potts NLS, et al. Discontinuation of clonazepam in social phobia. J Clin Psychopharmacol. In press
22. Versiani M, Nardi AE, Mundim FD, et al. The long-term treatment of social phobia with moclobemide. Int Clin Psychopharmacol 1996;11:83-88
23. Davidson JRT, Miner CM, De Veaugh-Geiss J, et al. The Brief Social Phobia Scale: a psychometric evaluation. Psychol Med 1997;27:161-166
24. Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol 1969; 33:448-457
25. Sutherland SM, Tupler LA, Colket JT, et al. A 2-year follow-up of social phobia: status after a brief medication trial. J Nerv Ment Dis 1996;184: 731-738
26. Versiani M, Mundim FD, Nardi AE, et al. Tranylcypromine in social phobia. J Clin Psychopharmacol 1988;8:279-283
27. Slaap BR, van Vliet IM, Westenberg HG, et al. Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response. J Affect Disord 1996;39:13-19